Your browser doesn't support javascript.
loading
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Vos, Joris L; Burman, Bharat; Jain, Swati; Fitzgerald, Conall W R; Sherman, Eric J; Dunn, Lara A; Fetten, James V; Michel, Loren S; Kriplani, Anuja; Ng, Kenneth K; Eng, Juliana; Tchekmedyian, Vatche; Haque, Sofia; Katabi, Nora; Kuo, Fengshen; Han, Catherine Y; Nadeem, Zaineb; Yang, Wei; Makarov, Vladimir; Srivastava, Raghvendra M; Ostrovnaya, Irina; Prasad, Manu; Zuur, Charlotte L; Riaz, Nadeem; Pfister, David G; Klebanoff, Christopher A; Chan, Timothy A; Ho, Alan L; Morris, Luc G T.
Afiliación
  • Vos JL; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Burman B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Jain S; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Fitzgerald CWR; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sherman EJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dunn LA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Fetten JV; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Michel LS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kriplani A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ng KK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Eng J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tchekmedyian V; Department of Medicine, Maine Medical Center-Tufts University School of Medicine, Portland, ME, USA.
  • Haque S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Katabi N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kuo F; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Han CY; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Nadeem Z; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yang W; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Makarov V; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Srivastava RM; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Ostrovnaya I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Prasad M; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zuur CL; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Riaz N; Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Pfister DG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Klebanoff CA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chan TA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ho AL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Morris LGT; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Med ; 29(12): 3077-3089, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37620627
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales / Carcinoma Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Salivales / Carcinoma Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos